Form 4: Pediatrix Medical Group Executive Lee Wood Reports Stock Grant and Tax Withholding

EVP Lee Wood reports acquisition of restricted shares and disposal for tax obligations related to vesting shares.

Summary

• Lee Wood, an EVP at Pediatrix Medical Group, reported acquiring 51,300 shares of common stock on June 1, 2024, as part of a restricted stock grant.
• These shares were granted under the company's Amended and Restated 2008 Incentive Compensation Plan.
• The shares vest in three tranches: 25% on June 1, 2025, 25% on June 1, 2026, and 50% on June 1, 2027.
• Wood also reported disposing of 813 shares on June 1, 2024, at a price of $7.31 per share to cover tax obligations related to vesting shares.
• Following these transactions, Wood directly owns 117,281 shares of Pediatrix Medical Group stock.

Sentiment

Score: 6

Explanation: Routine filing related to executive compensation; neutral impact.

Positives

• The grant of restricted shares to an executive suggests the company is incentivizing long-term performance.

Future Outlook

The vesting schedule of the restricted shares indicates a multi-year incentive plan for the executive.

Industry Context

Executive compensation through stock grants is a common practice in publicly traded companies to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in the healthcare industry, often benchmarked against peer companies of similar size and market capitalization.
• Vesting schedules are generally structured to incentivize long-term performance and retention, with three-year vesting periods being common.

Stakeholder Impact

• The stock grant aligns executive interests with shareholder value.

Key Dates